How effective is Aromasin for Breast Cancer ?

Summary

Overall ratings: 3.5/5
Long term ratings: 3.5/5

This is a reivew of how effective Aromasin (exemestane) is for Breast cancer and for what kind of people. The study is created by eHealthMe from 37 Aromasin users and is updated continuously.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on exemestane (the active ingredients of Aromasin) and Aromasin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Aromasin?

Aromasin has active ingredients of exemestane. It is often used in breast cancer. (latest outcomes from Aromasin 9,565 users)

What is Breast cancer?

Breast cancer has been reported by people with hormone replacement therapy, multiple sclerosis, rheumatoid arthritis, osteoporosis, breast cancer (latest reports from 135,583 Breast cancer patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

37 people are studied for taking Aromasin in Breast cancer


Overall effectiveness (number of people)

Does Aromasin work for your Breast cancer (overall)?

Long term effectiveness (number of people)

Does Aromasin work for your Breast cancer (long term)?

Aromasin effectiveness for Breast cancer (number of people)

Overall:
  • not at all: 1
  • somewhat: 4
  • moderate: 12
  • high: 15
  • very high: 5
Long Term:
  • not at all: 1
  • somewhat: 3
  • moderate: 9
  • high: 12
  • very high: 3

Gender of people who take Aromasin for Breast cancer *

  • female: 100 %
  • male: 0.0 %

Age of people who take Aromasin for Breast cancer *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 2.7 %
  • 40-49: 10.81 %
  • 50-59: 29.73 %
  • 60+: 56.76 %

Who finds Aromasin more effective for Breast Cancer?


Gender of people who take Aromasin for Breast cancer *

  • female: 100 %
  • male: 0.0 %

Age of people who take Aromasin for Breast cancer *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 15 %
  • 50-59: 25 %
  • 60+: 60 %

* Approximation only. Some reports may have incomplete information.


Do you take Aromasin?


You are not alone, use our "Ginger Health" app to:

  • connect with people like you who take Aromasin
  • use your healthcare experience to help people like you, and be rewarded



Related studies:



Recent updates

Recent general studies
Recent personal studies


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.